Mountain Wai Mountain: 2024 Annual Results Report Announcement

SZSIFeb 28 00:00 · Announcements

2024 Annual Results Express Announcement

SZSIFeb 28 00:00 · Announcements

Shanwai Mountain (688410.SH): Net income for the year 2024 is 74.0625 million yuan, a decrease of 61.92% year-on-year.

On February 27, Glonghui reported that Shanwaishan (688410.SH) released its performance quick report for 2024. During the reporting period, the company achieved revenue of 567.2754 million yuan, a decrease of 17.80% compared to the same period last year; it realized a net income attributable to the parent company's owners of 74.0625 million yuan, a decrease of 61.92% compared to the same period last year; it achieved a net income attributable to the parent company's owners after deducting non-operating gains and losses of 60.3541 million yuan, a decrease of 65.73% compared to the same period last year. In 2023, due to the promotion of critical illness capacity building policies, the company's high gross margin product—continuous blood purification.

Gelonghui FinanceFeb 27 21:07

Shanwai Shan (688410.SH) plans to use no more than 0.48 billion yuan (inclusive) of idle self-owned funds for Cash / Money Market management.

Gelonghui, on February 23, announced that Chongqing Shanwaishan Blood Purification Technology Co., Ltd. (hereinafter referred to as "the company") and its subsidiaries plan to use no more than 0.48 billion yuan (inclusive) of idle self-owned funds for Cash / Money Market management. The use of idle self-owned funds for Cash / Money Market management will be within twelve months from the date of approval by the Board of Directors, and the funds can be rolled over within the above limit and time period.

Gelonghui FinanceFeb 23 16:11

SWS Hemodialysis Care Shareholder to Trim Stake; Shares Down 4%

MT NewswiresFeb 13 14:58

Express News | Shanwaishan: Shareholder Zhuhai Xiuheng plans to reduce its shareholding by no more than 2.92% of the company's shares.

BreakingsFeb 12 23:07